Infervision Signs Agreement with Hainan Free Trade Port to Establish Medical AI Ecosystem and Regional Headquarters

Hainan Province is a national highland for the medical and health industry.

VCBeat (WeChat: vcbeat) has learned that on July 18, the centralized commencement and signing ceremony for the Hainan Free Trade Pilot Zone Construction Projects (Fifth Batch), with a sub-venue in Sanya, was held at the site of the Sanya Joy City Global Center project. Infervision, as the only high-tech enterprise focused exclusively on medical AI, attended the event to sign agreements and establish its presence in Hainan.

Infervision, together with ten universities and enterprises—including the Central University of Finance and Economics, China’s leading finance-focused university, and Beijing Foreign Enterprise Service Group Co., Ltd., the nation’s largest human resources company by operational scale—has become a partner in the Hainan Free Trade Pilot Zone construction projects.

To accelerate the layout of medical and health industry projects and promote further development in sectors such as healthcare, the Hainan Free Trade Zone has attracted high-quality enterprises to establish their presence. Following the signing of the agreement, Infervision will establish its regional headquarters in the Hainan Free Trade Zone. It will collaborate with renowned domestic and international specialized oncology hospitals to build a Cancer Research Center and an International High-End AI Medical Imaging Center. By introducing top-tier medical resources from leading cancer research institutions both at home and abroad, the initiative will facilitate scientific research sharing in areas including medical imaging, electronic medical records, laboratory test reports, and healthcare information systems.

Meanwhile, with the support of relevant policies from the Sanya Municipal Government, we will strengthen international and domestic exchanges of scientific research achievements, achieve the organic integration of medical big data with clinical practice, ensure the genuine localization of AI-powered medical imaging in the Hainan Free Trade Zone, and build a global platform for remote consultation.

Secondly, Infervision will establish a Medical AI Talent Training Center in Sanya. Leveraging the AI Medical Imaging Center, it will connect with all public medical institutions and primary community healthcare facilities within the jurisdiction of the Sanya Municipal Government. By fully utilizing the tiered diagnosis and treatment model—characterized by initial consultations at the primary level, two-way referrals, separate management of acute and chronic conditions, and coordination between upper- and lower-level institutions—the company will simultaneously build a National Center for Medical AI Data Professionals to handle big data processing for remote medical imaging diagnostics. Through the application of new concepts and technologies, Infervision aims to innovate medical service models, enhance the quality and efficiency of healthcare services, and support Sanya in strengthening its primary healthcare capabilities.

Infervision will collaborate with the Sanya Municipal Government to establish the Hainan Internet Hospital, further exploring and optimizing medical payment processes involving basic medical insurance and commercial health insurance. By supporting initiatives such as online payment systems and health credit frameworks, the partnership aims to provide patients with faster and more convenient services during online follow-up consultations and post-diagnosis rehabilitation.

Over the past four years since its establishment, Infervision has been dedicated to leveraging deep learning technology to analyze medical imaging data, including DR, CT, and MRI scans, providing physicians with precise and efficient auxiliary tools to alleviate their workload. Currently, more than 300 hospitals worldwide have established partnerships with Infervision.

Infervision AI Scholar Research Platform InferScholar® Center

To date, Infervision has successfully deployed and implemented its innovative medical AI products, including the InferRead® CT Lung intelligent solution for pulmonary diseases, the InferRead® DR Chest intelligent solution for thoracic diseases, the InferRead® CT Stroke solution for stroke, the InferRead® CT Bone solution for bone diseases, the InferRead® MG Breast solution for breast diseases, and the InferScholar® Center AI research platform. As one of the first batch of signing partners in the Hainan Free Trade Zone, Infervision will shoulder significant social responsibilities, drive the development of high-tech industries, grow alongside the Hainan Free Trade Zone, and extend the benefits of Chinese innovation to audiences both domestically and internationally.